Papers - HATAKEYAMA SHINGO
-
A Novel Strategy for Evasion of NK Cell Immunity by Tumours Expressing Core2 O-glycans.
Tsuboi S, Sutoh M, Hatakeyama S, Hiraoka N, Habuchi T, Horikawa Y, Hashimoto Y, Yoneyama T, Mori K, Koie T, Nakamura T, Saitoh H, Yamaya K, Funyu T, Fukuda M and Ohyama C.
EMBO J 2011.6
-
Perioperative Factors Associated With Postoperative Delirium in Patients Undergoing Noncardiac Surgery: An Individual Patient Data Meta-Analysis.
Sadeghirad B, Dodsworth BT, Schmutz Gelsomino N, Goettel N, Spence J, Buchan TA, Crandon HN, Baneshi MR, Pol RA, Brattinga B, Park UJ, Terashima M, Banning LBD, Van Leeuwen BL, Neerland BE, Chuan A, Martinez FT, Van Vugt JLA, Rampersaud YR, Hatakeyama S, Di Stasio E, Milisen K, Van Grootven B, van der Laan L, Thomson Mangnall L, Goodlin SJ, Lungeanu D, Denhaerynck K, Dhakharia V, Sampson EL, Zywiel MG, Falco L, Nguyen AV, Moss SJ, Krewulak KD, Jaworska N, Plotnikoff K, Kotteduwa-Jayawarden S, Sandarage R, Busse JW, Mbuagbaw L.
2023.8
-
Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes.
Bao X, Moseman EA, Saito H, Petryanik B, Thiriot A, Hatakeyama S, Ito Y, Kawashima H, Yamaguchi Y, Lowe JB, von Andrian UH, Fukuda M.
Immunity. 2010.11
-
Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.
Bao X, Kobayashi M, Hatakeyama S, Angata K, Gullberg D, Nakayama J, Fukuda MN, Fukuda M.
Proc Natl Acad Sci U S A. 21 ( 7 ) 12109 - 12114 2009.7
-
Identification of mRNA splicing factors as the endothelial receptor for carbohydrate-dependent lung colonization of cancer cells
Hatakeyama S, Kazuhiro Sugihara, Jun Nakayama , Tomoya O. Akama, Suk-Man Annie Wong, Hiroto Kawashima, Jianing Zhang , David F. Smith, Chikara Ohyama, Minoru Fukuda, and Michiko N. Fukuda.
Proc Natl Acad Sci U S A. 106 ( 9 ) 3095 - 3100 2009.3
-
Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter Study.
Ozaki K, Yamamoto H, Sekine Y, Horiguchi H, Hosogoe S, Mikami J, Fujita N, Tokui N, Okita K, Okamoto T, Mori K, Kobayashi M, Numakura K, Yoneyama T, Tabata R, Sato S, Habuchi T, Ohyama C, Hatakeyama S.
Int J Urol 32 2025.3
-
Efficacy of valganciclovir prophylaxis in kidney transplant recipients following low-dose rituximab induction therapy: a multicenter retrospective study.
Takehara T, Nishida H, Ichikawa K, Nawano T, Takai S, Fukuhara H, Matsuura T, Maita S, Saito M, Murakami R, Hatakeyama S, Obara W, Saitoh H, Ohyama C, Habuchi T, Watanabe M, Tsuchiya N.
Clin Exp Nephrol. 29 2025.3
-
Penile metastasis from a duodenal gastrointestinal stromal tumor: A rare case report.
Yoneyama F, Okamoto T, Hamaya T, Kodama H, Fujita N, Yamamoto H, Imai A, Hatakeyama S.
2025.2
-
Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy.
Hara S, Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kimura T; Japan Urological Oncology Group.
32 2025.2
-
Validation of five prognostic models treated with axitinib beyond first-line nivolumab plus ipilimumab therapy for metastatic renal cell carcinoma: a Japanese multicenter retrospective study.
Kikuchi H, Osawa T, Matsushita Y, Kojima T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Ueda K, Tanaka H, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Kato T, Hara H, Ito Y, Kitamura H, Miyake H, Shinohara N
2025.2
-
Primary resistance to nivolumab plus ipilimumab therapy affects second-line treatment outcomes in patients with metastatic renal cell carcinoma.
Mori K, Numakura K, Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Yamana K, Kandori S, Kimura T, Nishiyama N, Bando Y, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Kitamura H, Miyake H, Habuchi T.
Cancer Sci. 116 2025.2
-
Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone-sensitive prostate cancer: A multicenter study.
Yanagisawa T, Fukuokaya W, Hatakeyama S, Narita S, Muramoto K, Katsumi K, Takahashi H, Urabe F, Mori K, Tashiro K, Iwatani K, Shimomura T, Habuchi T, Kimura T.
Prostate. 85 2025.2
-
特集 今のうちにしっかり理解 最新の前立腺癌診療と近未来予想図 〈治療〉 高リスク前立腺癌に対するネオアジュバント内分泌化学療法を用いた手術療法
米山 高弘, 山本 勇人, 畠山 真吾
臨床泌尿器科 79 ( 1 ) 56 - 62 2025.1
-
特集 今のうちにしっかり理解 最新の前立腺癌診療と近未来予想図 企画にあたって 今のうちにしっかり理解 最新の前立腺癌診療と近未来予想図
畠山 真吾
臨床泌尿器科 79 ( 1 ) 5 - 5 2025.1
-
Prognostic model for second progression-free survival and overall survival in patients with high-risk metastatic hormone-sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy. 🗍
85 73 2025.1
-
Reproductive organ involvement in women undergoing radical cystectomy for urothelial bladder cancer: a nationwide multicenter study.
🗍� Kato M, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Yamamoto S, Matsue T, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Uchida J; Japan Urological Oncology Group.
Int J Clin Oncol. 2024.12
-
Development and validation of a model to predict the outcomes of radical cystectomy in patients with bladder cancer. 🗍
Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Nishiyama N, Nishiyama H, Kitamura H, Kimura T.
31 2024.12
-
Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy
Miura H, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Moriyama S, Oishi T, Horiguchi H, Soma O, Noro D, Tanaka T, Okamoto T, Yamamoto H, Sato S, Ohyama C.
Int J Urol 31 1330-1336 2024.12
-
Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer.
Miura H, Yamamoto H, Okuyama Y, Ishi N, Tanaka R, Oishi T, Yoneyama F, Hamaya T, Togashi K, Fujita N, Okamoto T, Ohyama C, Hatakeyama S
Cancer medicine 13 ( 24 ) e70226 2024.12
-
The first detailed annual record on the National Clinical Database Urology Division in Japan: A report on five surgical procedures.
Kikuchi E, Yamamoto H, Yasui T, Hatakeyama S, Mizuno R, Sakamoto S, Mizuno K, Morizane S, Hayakawa N, Kobayashi T, Kamoto T, Eto M
International journal of urology : official journal of the Japanese Urological Association 31 ( 12 ) 1344 - 1355 2024.12